Drug Trial Radar · NCT04701983
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,127
Actual
Start
Dec 16, 2020
Primary completion
Apr 11, 2025
Study completion Aug 27, 2025
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- Collaborators
- Regeneron Pharmaceuticals
- First posted
- Jan 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: * Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on occurrence of acute exacerbation of COPD (AECOPD) in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on severe AECOPD in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on corticosteroid-treated AECOPD in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on respiratory symptoms in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on Forced Expiratory Volume in 1 second (FEV1) slope in former smokers with moderate-to-severe COPD * Evaluate the efficacy of itepekimab compared with placebo on health-related quality of life (HRQoL) as assessed by St. George's Respiratory Questionnaire (SGRQ) in former smokers with moderate-to-severe COPD * Evaluate the safety and tolerability of itepekimab in former smokers with moderate-to-severe COPD * Evaluate the pharmacokinetic (PK) profile of itepekimab in former smokers with moderate-to-severe COPD * Evaluate immunogenicity to itepekimab in former smokers with moderate-to-severe COPD
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
Itepekimab SAR440340Drug
* Pharmaceutical form: solution for injection in pre-filled syringe * Route of administration: subcutaneous
PlaceboDrug
* Pharmaceutical form: solution for injection in pre-filled syringe * Route of administration: subcutaneous
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Rate of Adjudicated Moderate or Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD) Events Over the Placebo-Controlled Treatment PeriodTime frame: Baseline (Day 1) up to Week 52 for initial randomized participants; Baseline (Day 1) up to Week 24 to 52 for additional randomized participants
Locations
232 sites in 21 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Site Number : 8400012
Birmingham, Alabama
Jasper Summit Research Site Number : 8400178
Jasper, Alabama
Chandler Clinical Trials (Elite Clinical Network) Site Number : 8400034
Chandler, Arizona
Pulmonary Associates Site Number : 8400392
Phoenix, Arizona
Noble Clinical Research Site Number : 8400182
Tucson, Arizona
Tucson Clinical Research Institute Site Number : 8400431
Tucson, Arizona
California Research Institute Site Number : 8400400
Huntington Park, California
Modena Allergy + Asthma Site Number : 8400036
La Jolla, California
Imax Clinical Trials LLC 1 Site Number : 8400419
La Palma, California
Downtown LA Research Center Inc. Site Number : 8400027
Los Angeles, California
MACRO Trials Site Number : 8400030
Los Angeles, California
Antelope Valley Clinical Trials Site Number : 8400003
Northridge, California
~Alpine Clinical Research Center Site Number : 8400180
Boulder, Colorado
Innovative Clinical Research Site Number : 8400017
Lafayette, Colorado
Clin Research W Florida Site Number : 8400004
Clearwater, Florida
Beautiful Minds Clinical Research Center Site Number : 8400037
Cutler Bay, Florida
Indago Research and Health Center Site Number : 8400187
Hialeah, Florida
Advanced Clinical Research Site Number : 8400409
Kendall, Florida
Advanced Pulmonary Research Institute Site Number : 8400455
Loxahatchee Groves, Florida
University of Miami/Miami VA Medical Center Site Number : 8400026
Miami, Florida
DL Research Solutions Inc Site Number : 8400033
Miami, Florida
Reliant Medical Research Site Number : 8400397
Miami, Florida
Research Institute of South Florida,Inc Site Number : 8400006
Miami, Florida
PROLIVE MEDICAL RESEARCH Site Number : 8400420
Miami, Florida
Reed Medical Research Site Number : 8400032
Miami, Florida
High Quality Research Site Number : 8400406
Miami, Florida
Deluxe Health Center Site Number : 8400188
Miami Lakes, Florida
Florida Institute for Clinical Research Site Number : 8400013
Orlando, Florida
Tellabio International Research Services Site Number : 8400411
Pembroke Pines, Florida
Avanza Medical Research Center Site Number : 8400376
Pensacola, Florida
Broward Pulmonary and Sleep Specialists Site Number : 8400031
Plantation, Florida
Coastal Medical Research Institute Site Number : 8400044
St. Petersburg, Florida
Pasadena Center for Medical Research Site Number : 8400043
St. Petersburg, Florida
AdtreMed Site Number : 8400442
Tampa, Florida
Premier Medical Associates Site Number : 8400388
The Villages, Florida
Appalachian Clinical Research Site Number : 8400024
Adairsville, Georgia
Covenant Pulmonary Critical Care Site Number : 8400183
Atlanta, Georgia
David Kavtaradze MD, Inc. Site Number : 8400029
Cordele, Georgia
Alpha Clinical Research Georgia Site Number : 8400190
Dunwoody, Georgia
Gwinnett Biomedical Research Site Number : 8400007
Lawrenceville, Georgia
Showing 40 of 232 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.